Ligand validation:2NX3

A5P: ARABINOSE-5-PHOSPHATE

A5P is a Ligand Of Interest in 2NX3 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2NX3_A5P_I_269	57%	23%	0.16	0.934	1.73	1.45	2	2	3	0	100%	1
2NX3_A5P_A_269	56%	24%	0.18	0.952	1.74	1.4	2	2	3	0	100%	1
2NX3_A5P_B_269	53%	24%	0.168	0.93	1.73	1.38	2	2	6	0	100%	1
2NX3_A5P_H_269	51%	25%	0.178	0.933	1.73	1.35	2	1	3	0	100%	1
2NX3_A5P_J_269	40%	24%	0.188	0.899	1.73	1.39	2	3	2	0	100%	1
2NX3_A5P_C_269	39%	23%	0.172	0.88	1.74	1.43	2	2	3	0	100%	1
2NX3_A5P_G_269	33%	23%	0.205	0.886	1.73	1.43	2	2	3	0	100%	1
2NX3_A5P_E_269	22%	24%	0.214	0.831	1.73	1.38	2	2	0	0	100%	1
2NX3_A5P_F_269	20%	25%	0.232	0.838	1.73	1.35	2	2	5	0	100%	1
2NX3_A5P_K_269	13%	24%	0.234	0.777	1.73	1.4	2	2	1	0	100%	1
2NX3_A5P_L_269	3%	24%	0.318	0.66	1.74	1.39	2	2	1	0	100%	1
2NWS_A5P_A_1269	71%	1%	0.125	0.947	2.67	5.96	4	12	1	0	100%	1
2EF9_A5P_A_1269	66%	7%	0.136	0.942	2.44	2.4	3	7	3	0	100%	1
1T8X_A5P_A_1269	66%	11%	0.123	0.928	2.09	2.12	2	7	0	0	100%	1
1LRQ_A5P_A_1269	65%	3%	0.145	0.948	1.49	4.52	1	9	0	0	100%	1
1FXQ_A5P_A_1269	63%	1%	0.13	0.925	1.6	5.79	1	9	1	0	100%	1
3UPB_A5P_A_1601	97%	51%	0.064	0.98	0.9	1	1	1	0	0	100%	1
3UND_A5P_A_301	95%	52%	0.082	0.984	0.69	1.17	-	2	2	0	100%	0.6
3TMQ_A5P_C_282	81%	26%	0.113	0.965	0.89	2.06	1	2	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.